MAIA Biotechnology announces $736,600 private placement of common stock and warrants

MAIA Biotechnology, Inc.

Private placement of 603,769 shares at $1.22 per share with warrants to purchase 603,769 shares at $1.52.
Gross proceeds ~$736,600; warrants exercisable after six months, three-year term.
Proceeds to fund Step 1 of Part C of Phase II trial THIO-101 for NSCLC and for working capital.
Closing expected October 15, 2025; securities issued as restricted, no registration rights.
Offering exempt under Section 4(a)(2)/Reg D; shares and underlying not registered.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.